Allelotype of Human Ovarian Cancer

Cancer Research

Volumn 51, Issue 19, 1991, Pages 5118-5122

  Sato, Takaaki ^a   Saito, Hiroko ^a   Morita, Ryoji ^a   Nakamura, Yusuke ^a   Koi, Sumiko ^a   Lee, Je H ^b  

^a CANCER INSTITUTE   (Japan)

^b Experimental Pathology Laboratory   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME; CLINICAL ARTICLE; CYSTADENOCARCINOMA; FEMALE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CYSTADENOCARCINOMA; DNA PROBES; FEMALE; GENES, SUPPRESSOR; GENETIC MARKERS; GENOTYPE; HETEROZYGOTE; HUMAN; OVARIAN NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0025941543     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Vogelstein, B., Fearon, E. R., Hamilton, S. R. Kern, S. E. Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319:525-532, 1988.
2. Chen, L-C., Dollbaum, C., and Smith, H. S. Loss of heterozygosity on chromosome lq in human breast cancer. Proc. NaU. Acad. Sci. USA, 86: 7204-7207,1989.
3. Devilee, P., Van den Broek, M., Kuipers-Djjkshoom, N., Kolluri, R., Meera Khan, P. M., Pearson, P. L., and Cornelisse, C. J. At least four different chromosomal regions are involved in loss of heterozygosity in human breast cancer. Genomics, 5: 554-560,1989.
4. Lundberg, C., Skoog, L., Cavenee, W. K., and Norden-Slyold, M. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. Proc. Natl. Acad. Sci. USA, 84:2372-2376,1987.
5. Ali, I. U., Lindereau, R., Theillet, C., and Callahan, R. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science (Washington DC), 238:185-188,1987.
6. Mackay, J., Elder, P. A., Porteous, D. J., Steel, C. M., Hawkins, R. A., Going, J. J., and Chetty, U. Partial deletion of chromosome lip in breast cancer correlates with size of primary tumor and estrogen receptor level. Br. J. Cancer, 58:710-714,1988.
7. Mackay, J., Steel, M. C., Elder, D. A., Forrest, A. P. M., and Evans, H. J. Allele loss on the short arm of chromosome 17 in breast cancers. Lancet, 2: 1384-1385,1988.
8. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer Cumulative aUele losses promote tumor progression in primary breast cancer. Cancer Res., 50:7184-7189,1990.
9. Cropp, C. S., Lidereau, R., Campbell, G., Champene, M. H., and CaUahan, R. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc. NaU. Acad. Sci. USA, 87: 7737-7741,1990.
10. Morita, R., Ishikawa, J., Tsutsumi, M., Hilgi, K., Tsukada, Y., Kamidono, S., Maeda, S., and Nakamura, Y. Allelotype of renal cell carcinoma. Cancer Res., 57:820-823,1991.
11. Zbar, B., Brauch, H., Talmadge, C., and Linehan, M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.), 327:721-724,1987.
12. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K., and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51:89-93,1991.
13. Naylor, S. L., Johnson, B. E., Minna, J. D., and Sakaguchi, A. Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (Lond.), 329:451-454,1987.
14. Kok, K., Osigna, J., Carritt, B., Davis, M. B., van der Hout, A. H., van der Veen, A. Y., Landsvater, R. M., de Leu, L F. M. H., Berendsen, H. H.,Postmus, P. E., Poppema, S., and Buys, C. H. M. Deletion of a DNA sequence at chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.), 330:578-581, 1987.
15. Yokota, J., Wada, M., Shimosato, Y., Terada, M., and Sugimura, T. Loss of heterozygosity on chromosome 3,13 and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84:9252-9256, 1987.
16. Fearon, E. R., Feinberg, A. P., Hamilton, S. R., and Vogelstein, B. Loss of genes on chromosome 1 lp in bladder cancer. Nature (Lond.), 318:377-380, 1985.
17. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigen-esis. Cell, 61: 759-767, 1990.
18. Lee, J. H., Kavanagh, J. J., Wildrick, D. M., Wharton, J. T., and Blick, M. Frequent loss of heterozygosity on chromosome 6q, 11, and 17 in human ovarian cancer. Cancer Res., 50: 2724-2728,1990.
19. Lee, J. H., Kavanagh, J. J., Wharton, J. T., Wildrick, D. M., and Blick, M. Allele loss at the c-H-nzsl locus in human ovarian cancer. Cancer Res., 49: 1220-1222, 1989.
20. Ehlen, T., and Dubeau, L. Loss of heterozygosity on chromosomal segments 3p, 6q and 1 lp in human ovarian carcinomas. Oncogene, 5:219-223, 1990.
21. Nakamura, Y., Leppert, M., O'Connell, P., WolfT, R., Holm, T., Culver, M., Martin, G., Fujimoto, E., Hoff, M., Kumlin, E., and White, R. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science (Washington DC), 235: 1616-1622,1987.
22. Japan Society of Obstetrics and Gynecology, The Japanese Society of Pa thology. The General Rules for Clinical Pathological Management of Ovarian Tumors: Histopathological Classification, pp. 1-50. Tokyo, Japan: Kane-hara, 1990.
23. Kidd, K. K., Klinger, H. P., and Ruddle, F. H. Human gene mapping 10. Cytogenet. Cell Genet., 51:1-1148,1989.
24. Yamakawa, K., Takahashi, E-I., Saito, H., Sato, T., Oshimura, M., Hori, T.A., and Nakamura, Y. Isolation and mapping of 75 new DNA markers on human chromosome 3. Genomics, 9:536-543,1991.
25. Tokino, T., Takahashi, E-I., Mori, M., Tanigami, A., Glaser, T., Park, J. W., Jones, C., Hori, T-A., and Nakamura, Y. Isolation and mapping of 62 new RFLP markers on human chromosome 11. Am. J. Hum. Genet., 48: 258-268, 1991.
26. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244:207-211,1989.
27. Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B., Mackenzie, I. M., Cranston, G., Chetty, U., Mackay, J., Macdonald, M., Nakamura, Y., Heyheim, B., and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336:761-763, 1990.
28. Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., and King, M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science (Washington DC), 250:1684-1689,1990.
29. Wake, N., Hreshchyshyn, M. M., Piver, S. M., Matsui, S-I., and Sandberg, A. A. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res., 40:4512-4518, 1980.